MAM
KZR

Martingale Asset Management’s Kezar Life Sciences KZR Stock Holding History

Martingale Asset Management’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,222
Closed -$69.5K – 844
2023
Q1 		$69.5K Sell
2,222
-3,376
-60% -$195K ﹤0.01% 811
2022
Q4 		$394K Buy
+5,598
New +$415K 0.01% 667
2021
Q4 		– Sell
-2,612
Closed -$226K – 858
2021
Q3 		$226K Buy
+2,612
New +$173K ﹤0.01% 799
2020
Q4 		– Sell
-5,532
Closed -$268K – 976
2020
Q3 		$268K Sell
5,532
-9,570
-63% -$458K ﹤0.01% 926
2020
Q2 		$783K Buy
+15,102
New +$762K 0.01% 789

Other funds holding KZR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Martingale Asset Management's KZR Position: Q2 2023 in Review

Martingale Asset Management sold out of Kezar Life Sciences (KZR) in Q2 2023, closing a stake of 2,222 shares — an estimated $69.5K sold.

Martingale Asset Management first reported a position in KZR in Q2 2020 and held it in 5 quarters. The position peaked at $783K in Q2 2020. 104 funds tracked by Wall St. Rank hold KZR as of Q2 2023.

  • Martingale Asset Management reported no remaining Kezar Life Sciences position as of Q2 2023 after selling out during the quarter.
  • Martingale Asset Management sold 2,222 Kezar Life Sciences shares in Q2 2023, an estimated $69.5K.
  • Martingale Asset Management first reported a position in Kezar Life Sciences in Q2 2020 and held it in 5 quarters.
  • Martingale Asset Management's Kezar Life Sciences position peaked at $783K in Q2 2020.
  • 104 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q2 2023.

Based on Martingale Asset Management's 13F filing for Q2 2023, filed 11 Aug 2023.